A pioneering trial has begun to assess whether a simple finger-prick blood test could offer an early diagnosis for ...

Finger-prick blood test accurately detects Alzheimer’s biomarkers, enabling at-home collection and broader research ...

CITCCA data demonstrate more than 40% of high-risk stage I–III colorectal patients harbor molecular residual disease at clinical landmark, detectable only with ultrasensitive ctDNA testingMORRISVILLE, ...

A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...

Quest and Labcorp may be archrivals in the diagnostic testing market, but they appear to agree on at least one thing: the ...

Fluorophores are chemical compounds or molecules that absorb light energy at one wavelength and re-emit it as light at a ...

CITCCA study data demonstrate strong association between ctDNA status and recurrence risk in stage I-III colorectal cancerMORRISVILLE, N.C.--(BUSINESS WIRE)--#ASCOGI--SAGA Diagnostics, a pioneer in ...

“The non-invasive in vivo optical imaging of rhodopsin activation extends the diagnostic capability of ORG and may facilitate ...

A FINGER-prick blood test is being tested to see if it could be used to help diagnose Alzheimer’s disease before symptoms ...

A major international research project involving UCL is underway to test whether a finger prick-style blood test could be ...

Hospitals and health systems are increasingly partnering with AI companies to improve diagnostics and expand access to ...

Researchers at Utah State University revealed new details about CRISPR immune system defenses, such as Cas12a3 systems, that ...